Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-006809
Filing Date
2022-05-03
Accepted
2022-05-03 16:08:27
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20220331x10q.htm   iXBRL 10-Q 1925587
2 EX-10.1 rigl-20220331xex10d1.htm EX-10.1 29827
3 EX-10.2 rigl-20220331xex10d2.htm EX-10.2 141138
4 EX-31.1 rigl-20220331xex31d1.htm EX-31.1 15892
5 EX-31.2 rigl-20220331xex31d2.htm EX-31.2 16778
6 EX-32.1 rigl-20220331xex32d1.htm EX-32.1 9482
7 GRAPHIC rigl-20220331x10q004.jpg GRAPHIC 101003
  Complete submission text file 0001558370-22-006809.txt   7667931

Data Files

Seq Description Document Type Size
8 EX-101.SCH rigl-20220331.xsd EX-101.SCH 48839
9 EX-101.CAL rigl-20220331_cal.xml EX-101.CAL 50470
10 EX-101.DEF rigl-20220331_def.xml EX-101.DEF 204972
11 EX-101.LAB rigl-20220331_lab.xml EX-101.LAB 447837
12 EX-101.PRE rigl-20220331_pre.xml EX-101.PRE 326886
63 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20220331x10q_htm.xml XML 1208384
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 22886889
SIC: 2834 Pharmaceutical Preparations